University News

Ninety seven percent of Bentley University’s recent graduates are employed, attending or planning to attend graduate school, according to statistics from the Class of 2017 six months after their graduation. And Bentley graduates’ salaries are on the rise, with a median starting salary of $57,000, up from $55,000 last year.

Bentley University is bringing its nationally-recognized career-search expertise to new audiences with the launch of a podcast that offers career advice to professionals and job seekers.

Bentley President Gloria Larson, along with guest experts, joined Bloomberg Radio’s Carol Massar and Cory Johnson, to talk about why it is more important than ever for higher education and industry to work together, and how creative partnerships can help ensure students are successful after graduation.

Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University.

Bentley University opened the doors to a new, state-of-the-art multipurpose arena that will host the university’s NCAA Division I hockey team and prominent university events such as career fairs, high-profile speakers, alumni events and concerts.

Jillian Offermann ’20 wants people to “get pumped” about Bentley, and in Bentley’s new multipurpose arena, she will help do that.

Alison Davis-Blake, Ph.D., the former dean of the University of Michigan’s Ross School of Business and the University of Minnesota’s Carlson School of Management, has been appointed the eighth president of Bentley University, one of the top U.S. business schools in the country.

President-Elect Davis-Blake talks about growing up in an academic family and her belief in the power of education to change lives.

A question and answer session with President-Elect Davis-Blake about joining Bentley, her initial impressions of the university, and her background as the leader of large public business schools.

A recent published study from Bentley's Center for Integration of Science and Industry shows that the thirty year path from the initiation of research on oligonucleotides as therapeutics to the emergence of effective products followed predictable patterns of innovation, in which novel products are successfully developed only after the underlying basic research reaches a requisite level of maturity.